What happened at AAIC 2017? Be the first to know.

Fighting the disease. Helping those affected. Help us do both. Having trouble reading this email? View it in your browser Care. Support. Research. Will you help?   Dear Tushar, The Alzheimer's Association International Conference® 2017 (AAIC®) has concluded, and we close this gathering of the field's leading dementia science researchers with renewed determination to work together to end this disease.   We can – and must – build on this momentum. We all must continue to work together to help the Alzheimer's Association address the global dementia crisis by providing education and support to the millions who face dementia every day, while advancing vital research toward methods of treatment, prevention and, ultimately, a cure.   Your support today is a symbol of your commitment to continue exploring the important findings announced at this conference, including: Brain amyloid PET scans may substantially impact medical management of people with dementia, according to interim results from the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study, which is led by the Alzheimer's Association and managed by the American College of Radiology. This data will be submitted to Medicare as supportive evidence for why scans should be covered by Medicare in the future. A small but intriguing new study investigated using a blood test for amyloid – a substance that accumulates in the brains of people with Alzheimer's. Blood tests are simpler than spinal taps and less expensive than PET scans – which is how we currently measure amyloid. More than one-third of global dementia cases may be preventable through addressing lifestyle factors, according to The Lancet Commission on Dementia Prevention, Intervention and Care. Please know that your support makes advances like these possible and provides ongoing care and support for those affected by this devastating disease. For a recap of the highlights from AAIC, read the latest ​updates or watch these videos.   The world's foremost Alzheimer's investigators, clinicians and care providers have returned to their important work. Now we must return to ours. Now more than ever, we rely on your support to move forward in this fight.   As we work to change the trajectory of Alzheimer's disease, we must continue to fight this disease on every front. Thank you for your gift to advance research while providing care and support every day to those affected by Alzheimer's.   Sincerely, Donna McCullough Chief Development Officer          P.S. We need your support to continue our research and to maintain vital care and support programs. If you can, please consider making a donation now.     Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support. Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 © 2017 Alzheimer's Association. All rights reserved. 800.272.3900 | alz.org® | Donate   Please add info@alz.org to your address book to ensure you receive all future emails.   View your email preferences or unsubscribe.